Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02128906
Title Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh

larynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oropharynx cancer


Cetuximab + Docetaxel


Age Groups: adult
Covered Countries USA

No variant requirements are available.